Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
441 Leser
Artikel bewerten:
(2)

Aino Health AB (publ): Aino Health interim report January-march 2023

Strong license growth, Increased net sales, Improved results, Improved operative cash flow

January-March 2023

• Net sales were KSEK 6,180 (5,424)

• Profit/loss after financial items was KSEK -2,791 (-3,722)

• Earnings per share were SEK -0.1 (-0.1)


We are proud to present our continued success and the latest news from Q1 2023. Happily, we can announce that our focus on increased license growth has had results. Compared with the same period last year, we have experienced an increase

in licenses of around fifty percent. This is a large milestone for us, and proof that our SaaS solution is in demand and appreciated on the market. Not only licenses have increased - our profitability and operative results have also improved significantly.

During Q1 2023, yet another Finnish welfare area, encompassing around 7,400 employees, has chosen Aino's SaaS solution. Implementation of the solution is expected to occur toward the end of the third quarter 2023. This agreement reinforces our growing footprint in the public sector and confirms our position as a leading player in Human Capital Management.

Another big step for Aino Health during the quarter is the close collaboration initiated with Visma Public Finland, one of the main suppliers of wage and HR systems in the Nordic region. Visma Public's software includes functionality for wage slips, produced monthly for 250,000 public administration employees. This collaboration strengthens our position on the Nordic market and the offer to our client base in the public sector.

Aino Health has also had success on the Finnish market, with another Finish municipality, Lapinlahden kunta, choosing our SaaS solution. The agreement covers a total of around 320 employees and the implementation is expected to occur toward the end of the second quarter 2023. This shows our commitment to offering effective solutions for Employee Sustainability at a local level as well.

These events show that Aino Health is continuing to build on the successes of 2022, where we most recently, in the fourth quarter, signed several new agreements with organisations and companies vital to society. The license growth of around sixty percent last year indicates strong growth in important industries that are vital to society, such as healthcare, infrastructure, and transportation.

We are currently in a strong position to partake of and contribute to the global trends in our operative area. These trends include, among other things, a growing awareness of the importance of Human Capital Management and an increased demand for innovative digital solutions to promote a sustainable work environment for employees. We are convinced that these trends will continue to grow over the coming years and we look forward to continuously offering our clients marketleading solutions that meet and exceed their expectations.

The information contained herein is such as shall be made public by Aino Health AB (publ), in accordance with the EU Market Abuse Regulation. This information was made public, through the agency of Jyrki Eklund, CEO and President of Aino Health AB, at 08.30 AM CET on May 16, 2023.


For more information
Jyrki Eklund
CEO Aino Health
Phone: +358 40 042 4221
jyrki.eklund@ainohealth.com

Certified adviser
Erik Penser Bank
For more information see: https://investors.ainohealth.com/certified-adviser/

About Aino Health (publ)
Aino Health is the leading provider of Software as a Service solutions in Corporate Health Management.
The company's complete system of SaaS platforms and services reduces sick leave, lowers related costs and improves business outcomes through increased productivity and employee engagement by making health, well-being and safety an integral part of daily work. For more information visit ainohealth.com.


© 2023 GlobeNewswire (Europe)
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.